Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotoxicology: an overview.

J H Dean1, L M Thurmond

  • 1Department of Cell Biology, Research Triangle Park, North Carolina 27709.

Toxicologic Pathology
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conservation Values and Risk of Handling Bats: Implications for One Health Communication.

EcoHealth·2018
Same author

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.

Molecular psychiatry·2016
Same author

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.

Molecular psychiatry·2015
Same author

Health advocacy: a vital step in attaining human rights for adults with intellectual disability.

Journal of intellectual disability research : JIDR·2012
Same author

The effect on human sex ratio at birth by assisted reproductive technology (ART) procedures--an assessment of babies born following single embryo transfers, Australia and New Zealand, 2002-2006.

BJOG : an international journal of obstetrics and gynaecology·2010
Same author

Immunotoxicology: An overview.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same journal

New Approach Methodologies (NAMs) for Carcinogenicity Evaluation.

Toxicologic pathology·2026
Same journal

2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.

Toxicologic pathology·2026
Same journal

Toxicologic Pathology Forum*: Opportunities and Challenges in the Use of Artificial Intelligence in Nonclinical Toxicologic Histopathology Evaluations.

Toxicologic pathology·2026
Same journal

New Modalities and Carcinogenicity Assessment.

Toxicologic pathology·2026
Same journal

Second Joint Annual Congress of the British Society of Toxicologic Pathology and the European Society of Toxicologic Pathology Special Issue.

Toxicologic pathology·2026
Same journal

Hemangiosarcomas in Intercostal Brown Adipose Tissues of the Sternum Induced by Urethane in TgrasH2 Mice.

Toxicologic pathology·2026
See all related articles

Chemicals and drugs can harm the immune system, particularly during cell development. Validated rodent models and assays help predict immunotoxicity and immunopharmacology in humans.

Area of Science:

  • Immunotoxicology
  • Preclinical Toxicology
  • Drug Development

Background:

  • Chemicals and drugs can cause selective toxicity, affecting immunocompetent cell interactions during proliferation and differentiation.
  • Understanding immunotoxicity is crucial for assessing the safety of new chemical and drug agents.

Purpose of the Study:

  • To present validated in vivo and in vitro assays for assessing immunotoxicity and immunopharmacology in rodents.
  • To discuss the predictive value of rodent models for human extrapolation in toxicology.

Main Methods:

  • Development and validation of a flexible panel of sensitive in vivo and in vitro assays.
  • Sequential analysis methods combined with host resistance assays to define immunomodulation.
  • Comparative preclinical toxicology studies of immunosuppressive drugs in rodents.

Related Experiment Videos

Main Results:

  • Rodent models and assays effectively assess immunotoxicity and immunopharmacology.
  • Cyclosporin A studies demonstrated similar pharmacology and toxicity in rodents and humans.
  • Species differences in toxicology are often due to ADME or target tissue dose, not fundamental cell physiology differences.

Conclusions:

  • Validated rodent models are essential for predicting chemical and drug toxicity in humans.
  • Ongoing methods development is required due to expanding knowledge of immune system cell biology.
  • Rodent studies provide a basis for extrapolating toxicity data to human risk assessment.